Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

C024 - Soft Tissue Fillers: Video Instruction and Live Panel Discussion

Monday, March 4; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Apply advanced facial assessment skills and knowledge of nuanced injection anatomy to formulate comprehensive facial treatment plans.
  • Use techniques demonstrated with detailed video clips to achieve natural results with soft tissue fillers.

Description

During this session, master injectors will review detailed anatomy, discuss advanced facial assessment and formulate comprehensive facial treatment plans. Multiple concise videos from global experts will be utilized to systematically demonstrate advanced techniques for pan facial rejuvenation including needle techniques, cannulas and emerging indications. The final portion of this course will be dedicated to a case-based panel discussion in which master injectors from around the world perform facial assessments, synthesize treatment plans and discuss advanced injection techniques. This in-depth discussion, along with audience participation, ensures that attendees will take home multiple pearls that can be put into clinical practice immediately.

Disclosures

  • Bertucci, Vince, MD: Allergan, Inc – C(Fees); Allergan, Inc. – A(Fees), I(Fees), SP(H); Croma-Pharma GmbH Austria – A(NC); Galderma Canada, Inc – A(Fees), SP(H); Galderma Laboratories, L.P. – A(Fees); Galderma USA – I(Fees); La Roche-Posay Laboratorie Pharmaceutique – A(Fees), SP(Fees); Merz Aesthetics – A(Fees), C(Fees), I(Fees); Revance Therapeutics, Inc. – C(Fees), I(Fees), SP(Fees); TEOXANE Laboratories – A(OB); Valeant Pharmaceuticals International – C(Fees);
  • Braz, Andre, MD: Allergan, Inc – A(H), SP(H); Merz Pharmaceuticals, LLC – SP(Fees);
  • Cotofana, Sebastian, MD, PhD: no financial relationships exist with commercial interests.
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candela Corporation – A(H); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – I(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – A(NC); Valeant Pharmaceuticals North America LLC – C(H);
  • Fabi, Sabrina G., MD: Allergan, Inc – I(Grants/Research Funding), Speaker/Faculty Education(H); Bausch Health – C(H), I(Grants/Research Funding); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Endo International plc – C(H), I(Grants/Research Funding); Galderma Laboratories, LP – SP(H); Merz Aesthetics – I(Grants/Research Funding), Speaker/Faculty Education(H); Revance Therapeutics, Inc. – A(H), C(H), I(Grants/Research Funding); Roche Laboratories – Speaker/Faculty Education(H); SkinCeuticals LLC – SP(H);
  • Fitzgerald, Rebecca L., MD: Allergan, Inc – A(H), I(H), Speaker/Faculty Education(H); Evolus, Inc. – A(H); Galderma USA – Speaker/Faculty Education(H);
  • Glaser, Dee Anna, MD: Allergan, Inc. – I(Grants/Research Funding), O(H); American Society of Dermatologic Surgery – B(NC); Atacama Therapeutics – I(Grants/Research Funding); Brickell Biotech, Inc. – I(Grants/Research Funding); Dermira – A(H), I(Grants/Research Funding), Speaker/Faculty Education(H); Galderma Laboratories, L.P. – A(H); Galderma Research & Development, LLC – I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Unilever Home & Personal Care USA – A(H);
  • Hausauer, Amelia Kate, MD: Allergan, Inc – I(Grants/Research Funding); Eclipse Medical – C(H), I(EQ); Merz Aesthetics – SP(H); Recros Medica – I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Revive Advanced Training Consultants – Speaker/Faculty Education(H);
  • Humphrey, Shannon, MD: Allergan, Inc – Speaker/Faculty Education(H); Allergan, Inc. – A(H), I(Grants/Research Funding); Evolus, Inc. – I(H); Galderma Laboratories, L.P. – SP(H); Galderma Laboratories, LP – A(H); L'Oréal France – SP(H); Merz Aesthetics – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding), SP(H);
  • Jones, Derek H., MD: Allergan, Inc. – A(H), C(H), I(Grants/Research Funding), SP(H); Evolus, Inc. – I(Grants/Research Funding); Galderma USA – C(H), I(Grants/Research Funding); Kythera – C(H), I(Grants/Research Funding); Merz Pharmaceuticals, LLC – C(H), I(Grants/Research Funding), SP(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding);
  • Liew, Steven: Allergan, Inc. – Speaker/Faculty Education(H); Complete Face – O(OB);
Schedule
Monday, March 4
1:00 PM
Dr. Bertucci and Dr. Humphrey / Introduction
1:05 PM
Dr. Cotofana / Anatomy: Upper Face, Periocular and Nose
1:20 PM
Dr. Braz / Anatomy: Mid & Lower Face
1:35 PM
Dr. Fitzgerald / Facial Assessment & Treatment Planning: Contemplating Proportions
1:50 PM
Dr. Liew / Facial Assessment & Treatment Planning: A Plastic Surgeon’s Perspective
2:05 PM
Dr. Fabi, Dr. Jones, Dr. Fitzgerald, Dr. Humphrey, Dr. Bertucci, and Dr. Liew / Treatment Videos
3:15 PM
Dr. Cox, Dr. Glaser, Dr. Humphrey, Dr. Bertucci, and Dr. Hausauer / Case-Based Panel
Event Details
  • Date
    Monday, March 4
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 146C
  • CME Credits
    3.00
  • Type
    Ticketed
Directors/Co-Directors
  • Vince Bertucci, MD, FAAD
  • Shannon Humphrey, MD, FAAD
Speakers
  • Amelia Kate Hausauer, MD, FAAD
  • Andre Braz, MD
  • Dee Anna Glaser, MD, FAAD
  • Derek H. Jones, MD, FAAD
  • Rebecca L. Fitzgerald, MD, FAAD
  • Sabrina G. Fabi, MD, FAAD
  • Sebastian Cotofana, MD, PhD
  • Steven Liew
  • Sue Ellen Cox, MD, FAAD